Anaplastic Ependymoma — Trials

Anaplastic Ependymoma — Trials · CancerIndex

Clinical trials

Registered studies

31 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: Children's Oncology Group
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05278208	Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors	recruiting	Phase 1 / Phase 2	65	Nationwide Children's HospitalOTHER	1	Jul 20, 2026	clinicaltrials

Data updated 22 days agoSource updated Jul 20, 2026source: clinicaltrials